Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 41(10): 1716-28, 1998 May 07.
Article in English | MEDLINE | ID: mdl-9572898

ABSTRACT

The identification of L-739,943 (8b), a potent, orally bioavailable benzolactam growth hormone secretagogue, is obtained from zwitterionic L-692,429 through modification of its amino acid side chain and replacement of the acidic 2'-tetrazole with the neutral and potency enhancing 2'-(N-methylaminocarbonylamino)methyl substituent. L-739,943 is orally active for the release of growth hormone in beagle dogs at doses as low as 0.5 mg/kg. Oral bioavailability in dogs of 8b is 24% at a dose of 2 mg/kg with a mean drug Cmax of 145 +/- 46 ng/mL. L-739,943 represents a significant breakthrough in terms of both potency and oral bioavailability as compared to the prototype benzolactam L-692,429.


Subject(s)
Benzazepines , Growth Hormone/metabolism , Methylurea Compounds , Administration, Oral , Animals , Benzazepines/chemical synthesis , Benzazepines/chemistry , Benzazepines/pharmacokinetics , Benzazepines/pharmacology , Biological Availability , Cells, Cultured , Dogs , Female , Male , Methylurea Compounds/chemical synthesis , Methylurea Compounds/chemistry , Methylurea Compounds/pharmacokinetics , Methylurea Compounds/pharmacology , Pituitary Gland/cytology , Pituitary Gland/metabolism , Rats , Rats, Wistar , Structure-Activity Relationship , Tetrazoles/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...